Prevention of non-melanoma skin cancer.

被引:24
|
作者
Stratton S.P. [1 ]
机构
[1] Section of Hematology and Oncology, Arizona Cancer Center, College of Medicine, University of Arizona, Tucson, 85724, AZ
基金
美国国家卫生研究院;
关键词
Squamous Cell Carcinoma; Celecoxib; Skin Cancer; EGCG; Basal Cell Carcinoma;
D O I
10.1007/s11912-001-0080-x
中图分类号
学科分类号
摘要
Basal cell and squamous cell carcinomas comprise the majority of non-melanoma skin cancers. Whereas the incidence of skin cancer is equivalent to that of all other cancers combined, non-melanoma skin cancer receives a disproportionate share of attention because mortality is relatively low. However, the impact on public health is striking. This review is intended to update readers on the current findings in research on the prevention of these diseases. Topics covered include preventive strategies targeting high-risk populations, chemoprevention (including treatment of intraepithelial neoplasia), and an overview of recent and ongoing clinical and preclinical studies involving new chemopreventive agents.
引用
收藏
页码:295 / 300
页数:5
相关论文
共 50 条
  • [1] Non-melanoma skin cancer. Pathogenesis, prevalence and prevention
    Zink, A.
    HAUTARZT, 2017, 68 (11): : 919 - 928
  • [2] Familial aggregation of non-melanoma skin cancer.
    Mann, GJ
    Thoo, CHF
    Morgan, L
    Stewart, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 271 - 271
  • [3] Non-melanoma Skin Cancer in Canada Chapter 2: Primary Prevention of Non-melanoma Skin Cancer
    Barber, Kirk
    Searles, Gordon E.
    Vender, Ronald
    Teoh, Hwee
    Ashkenas, John
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (03) : 216 - 226
  • [4] Non-melanoma skin cancer: Pathogenesis, prevalence and prevention
    Zink A.
    Der Hautarzt, 2017, 68 (11): : 919 - 928
  • [5] Biomarkers in melanoma and non-melanoma skin cancer prevention and risk stratification
    Trager, Megan H.
    Geskin, Larisa J.
    Samie, Faramarz H.
    Liu, Liang
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (01) : 4 - 12
  • [6] High rate brachytherapy in the treatment of non-melanoma skin cancer.
    Gonzalez Ruiz, M. A.
    Saavedra Bejarano, J.
    Quiros Rivero, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1612 - S1612
  • [7] Serum carotenoids and α-tocopherol and risk of non-melanoma skin cancer.
    Dorgan, JE
    Boayke, NA
    Fears, TR
    Schleicher, RL
    Helsel, W
    Anderson, C
    Robinson, J
    Guin, JD
    Lessin, S
    Ratnasinghe, LD
    Tangrea, JA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1339S - 1339S
  • [8] Non-melanoma skin cancer
    Marks, R
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (04) : 235 - &
  • [9] Non-melanoma skin cancer
    Madan, Vishal
    Lear, John T.
    Szeimies, Rolf-Markus
    LANCET, 2010, 375 (9715): : 673 - 685
  • [10] Non-melanoma skin cancer
    Reeder, Anthony I.
    NEW ZEALAND MEDICAL JOURNAL, 2011, 124 (1329) : 99 - 100